Xiaolan Deng
Molecular Biology · 2015–2020
A researcher in the Science corpus: 8 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 188 citations into it
Whom Xiaolan Deng trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Ryuji Hamamoto
- Lianhua Piao
- S. Hayami
- Hyun-soo Cho
- Hans Clevers
- Yusuke Nakamura
- G. Toyokawa
- Masanori Yoshimatsu
- Takehiro Suzuki
- Makoto Nakakido
Who trusts Xiaolan Deng overall
Papers from Xiaolan Deng's perspective
Ordered by how strongly the researchers Xiaolan Deng trusts endorse each paper. Same corpus, a different order for every researcher.
- Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers
- SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells
- Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker
- A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5′ flanking region of SMYD3 is a risk factor for human cancers
- Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers
- Enhanced HSP70 lysine methylation promotes proliferation of cancer cells through activation of Aurora kinase B
- Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway
- Critical roles of non-histone protein lysine methylation in human tumorigenesis
- Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression.
- Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq (Nature)
Their papers
- Recognition of RNA N6-methyladenosine by IGF2BP Proteins Enhances mRNA Stability and Translation (2018) — 2,518 citations
- R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling (2017) — 977 citations
- METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification (2017) — 860 citations
- PRMT1 promotes mitosis of cancer cells through arginine methylation of INCENP (2015) — 36 citations
- Critical roles of SMYD2-mediated β-catenin methylation for nuclear translocation and activation of Wnt signaling (2017) — 43 citations
- RNA N6-methyladenosine modification in cancers: current status and perspectives (2018) — 614 citations
- Targeting FTO suppresses cancer stem cell maintenance and immune evasion (2020) — 658 citations
- WHSC1L1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancer (2017) — 44 citations